Faron Pharmaceuticals appoints Jurriaan Dekkers as Chief Financial Officer
December 3, 2025Faron Pharmaceuticals, chief financial officer
Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Jurriaan Dekkers as its new Chief Financial Officer (CFO). Dekkers most recently …
Medicus Pharma shares updates on basal cell carcinoma trials
December 2, 2025Research and Development Medicus Pharma, Oncology
Medicus Pharma has announced updates on the progress of SKNJCT-003 and SKNJCT-004, its clinical trials studying the efficacy of a …
Arnold & Porter appoints George Jenkins as partner
December 2, 2025Arnold & Porter, law, life sciences
Arnold & Porter has announced the appointment of George Jenkins as a partner in the firm’s Corporate & Finance practice. …
Safeguarding health and well-being for employees – the value of occupational health services
December 1, 2025Medical Communications Chartered Institute of Personnel and Development, Society of Occupational Medicine, employee health and well-being, occupational health, workplace sickness absence levels
With workplace sickness absence levels stuck at record levels, employers need to step-change how they think about and manage employee …
Men’s health – a new report from the Department of Health and Social Care
November 28, 2025Medical Communications Men's Health Strategy, Men's mental health, UK Department of Health and Social Care, medical communications, medical education, mental health
The UK Department of Health and Social Care has published a new report entitled Men’s health: a strategic vision for …
Healing the fracture in the system: the case for universal fraction liaison services access
November 28, 2025Medical Communications, Research and Development Osteoporosis
By Tina Backhouse In 2024, the UK government committed to achieving 100% coverage of Fracture Liaison Services (FLS)across the NHS …
Five Facts about antimicrobial resistance
November 28, 2025Medical Communications Antimicrobial resistance (AMR), Five Facts
1 Antimicrobial resistance (AMR) is when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents such as antibiotics.1 Around 35,000 …
Celltrion’s Remsima IV approved by EC in liquid form
November 27, 2025Research and Development Celltrion Inc, Immunology
Celltrion’s Remsima IV, the first-ever liquid formulation of infliximab for autoimmune diseases, has been approved by the European Commission (EC). …
One-carbon Therapeutics starts new cancer therapy trial
November 27, 2025Research and Development Oncology, One-carbon Therapeutics
Clinical-stage biotechnology company One-carbon Therapeutics has announced that the first subject has been dosed in its clinical trial for TH9619, …
Major breakthrough in T-cell receptor therapy manufacturing
November 27, 2025Manufacturing and Production Terumo BCT, cell therapy
For the first time, researchers at the University of Chicago in the US have successfully completed all three critical steps …
Gilead announces first shipments of HIV prevention drug to Eswatini and Zambia
November 27, 2025Product launch Gilead, HIV/AIDS
Gilead has announced the first shipments of its HIV prevention drug lenacapavir to Eswatini and Zambia, a milestone in the …
InnotiveDx gets £1m grant to advance UTI diagnostics system
November 27, 2025Research and Development Diagnostics, InnotiveDx, Urology
InnotiveDx has announced that it has received a £1m grant from Pathways to Antimicrobial Clinical Efficacy (PACE) to advance the …
Cellbyte raises $2.75m to fund pharma drug launch platform
November 27, 2025Product launch AI, Cellbyte, biotech
Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches. The complexity …
Accession Therapeutics doses first patient in new cancer immunotherapy trial
November 26, 2025Research and Development Accession Therapeutics, Oncology
Biopharmaceutical company Accession Therapeutics has announced the dosing of the first patient in the phase 1 clinical trial of TROCEPT-01 …
ViVac Pharma appoints Keren Leshem as CEO
November 26, 2025CEO, Oncology, ViVac Pharma
Early-stage biotechnology company ViVac Pharma has appointed Keren Leshem as its new CEO. Leshem brings almost 30 years of experience …
Alvotech biosimilar receives EC marketing approval
November 26, 2025Research and Development Alvotech, Immunology, Inflammatory disease, Rheumatology
The European Commission (EC) has granted marketing authorisation for Gobivaz, Alvotech’s first-in-market biosimilar of Simponi (golimumab), which is used for …
A community-first future: which pathways will get us there?
November 21, 2025Business Services Gateway to Local Adoption, NHS, Visions4Health, pharmacy
In the final Gateway to Local Adoption article of 2025, Visions4Health caught up with Julian Wenman, senior operations manager in …
Scitech Engineering joins Ekium Group, rebrands as Scitech-EKIUM
November 21, 2025Manufacturing and Production Ekium Group, Engineering, Good Manufacturing Production, Scitech Engineering, automation
Scitech Engineering, a provider of engineering and manufacturing services across multiple industries including life sciences, has joined the Ekium Group, …
M42 and Olive Rock agree ownership of UAE health assets
November 20, 2025Business Services M42, Olive Rock, UAE health assets
Global health company M42 and private equity firm Olive Rock Partners (ORP) have signed an agreement that will see the …
iZafe Group signs agreement with Skand for automated medication dispenser
November 20, 2025Business Services Skand, iZafe Group
iZafe Group have signed a distribution agreement with Skand for the launch of Dosell, a medication-dispensing robot, in Iceland. Dosell …
Latest content
FibroFind appoints Lee Borthwick as CEO
